Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age

Jessica Howell; David Anderson; Stephen Bloom; John Lubel; William Kemp; James Williams; Sally Bell; Catherine Croagh; Barbara Demediuk; Paul Desmond; Sam Hall; Jacinta Holmes; Thai Hong; David Iser; Lucy Lim; Timothy Papaluca; Marno Ryan; Kumar Visvanathan; Yinzong Xiao; Caroline van Gemert; Margaret Hellard; Alexander Thompson

doi:10.1016/j.jhep.2020.06.031

Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age

J Hepatol. 2020 Nov;73(5):1282-1284. doi: 10.1016/j.jhep.2020.06.031. Epub 2020 Sep 1.

Authors

Jessica Howell¹, David Anderson², Stephen Bloom³, John Lubel⁴, William Kemp⁴, James Williams⁵, Sally Bell⁶, Catherine Croagh⁵, Barbara Demediuk⁵, Paul Desmond⁷, Sam Hall⁷, Jacinta Holmes⁵, Thai Hong⁵, David Iser⁵, Lucy Lim⁵, Timothy Papaluca⁷, Marno Ryan⁵, Kumar Visvanathan⁷, Yinzong Xiao⁸, Caroline van Gemert⁹, Margaret Hellard¹⁰, Alexander Thompson⁷

Affiliations

¹ Department of Gastroenterology, St Vincent's Hospital Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia; Department of Medicine, University of Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia; Disease Elimination Program, Burnet Institute, 85 Commercial Rd, Melbourne 3004, Victoria, Australia; Department of Epidemiology and Disease Prevention, Monash University, 55 Commercial Rd, Melbourne 3004, Victoria, Australia. Electronic address: [email protected].
² Global Diagnostics Development Program, Burnet Institute, 55 Commercial Rd, Melbourne 3004, Victoria, Australia.
³ Eastern Health, 8 Arnold Street, Box Hill 3128, Victoria, Australia.
⁴ Department of Medicine, Monash University, 55 Commercial Rd, Mlebourne 3004, Victoria, Australia; Alfred Hospital, 55 Commercial Rd, Mlebourne 3004, Victoria, Australia.
⁵ Department of Gastroenterology, St Vincent's Hospital Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia.
⁶ Department of Medicine, Monash University, 55 Commercial Rd, Mlebourne 3004, Victoria, Australia.
⁷ Department of Gastroenterology, St Vincent's Hospital Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia; Department of Medicine, University of Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia.
⁸ Department of Gastroenterology, St Vincent's Hospital Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia; Department of Medicine, University of Melbourne, 41 Victoria Pde, Fitzroy 3068, Victoria, Australia; Disease Elimination Program, Burnet Institute, 85 Commercial Rd, Melbourne 3004, Victoria, Australia.
⁹ Disease Elimination Program, Burnet Institute, 85 Commercial Rd, Melbourne 3004, Victoria, Australia.
¹⁰ Disease Elimination Program, Burnet Institute, 85 Commercial Rd, Melbourne 3004, Victoria, Australia; Department of Epidemiology and Disease Prevention, Monash University, 55 Commercial Rd, Melbourne 3004, Victoria, Australia; Alfred Hospital, 55 Commercial Rd, Mlebourne 3004, Victoria, Australia.

PMID: 32888765
DOI: 10.1016/j.jhep.2020.06.031

No abstract available

Keywords: Antiviral therapy; Resource-limited settings; Treatment guidelines; Validation; Viral hepatitis.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Africa
Hepatitis B e Antigens
Hepatitis B virus
Hepatitis B* / drug therapy
Hepatitis B, Chronic* / drug therapy
Humans
Patient Selection

Substances

Hepatitis B e Antigens